Related Experiment Videos
Invasive diagnostic approaches to pulmonary infiltrates
1Washington University School of Medicine, St Louis, MO 63110.
Summary
Diagnosing lung disease in organ transplant recipients is challenging. Fiberoptic bronchoscopy is now the preferred initial diagnostic tool, often replacing invasive surgical lung biopsies.
Area of Science:
- Pulmonology
- Transplant Medicine
- Infectious Diseases
Background:
- Pulmonary disease diagnosis in organ transplant recipients is complex, often requiring invasive procedures.
- Distinguishing infectious from noninfectious causes and identifying specific pathogens can be difficult.
- Early methods like transtracheal aspiration had limitations, especially for opportunistic infections.
Purpose of the Study:
- To review the diagnostic approaches for pulmonary disease in organ transplant recipients.
- To highlight the evolution of diagnostic techniques and their indications.
- To establish the current role of bronchoscopy and lung biopsy.
Main Methods:
- Review of diagnostic procedures for pulmonary disease in immunosuppressed patients.
- Comparison of transtracheal aspiration, fiberoptic bronchoscopy, and surgical lung biopsy.
- Analysis of diagnostic yield and morbidity associated with each procedure.
Main Results:
- Fiberoptic bronchoscopy, introduced in the 1970s, revolutionized pulmonary disease diagnosis in immunosuppressed patients.
- Bronchoscopy is now the initial procedure of choice due to its diagnostic success and low morbidity.
- Surgical lung biopsy is reserved for cases where bronchoscopy fails or is contraindicated.
Conclusions:
- Fiberoptic bronchoscopy is the primary diagnostic modality for pulmonary disease in organ transplant recipients.
- The efficacy of bronchoscopy has reduced the need for surgical lung biopsies.
- Accurate diagnosis is crucial for initiating appropriate therapy in this vulnerable patient population.